A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

2,480

Participants

Timeline

Start Date

April 10, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

October 30, 2024

Conditions
Rabies Vaccine Adverse ReactionSafety and Efficacy
Interventions
BIOLOGICAL

Freeze-dried human rabies vaccine (Vero cells) Zhifeilongkoma - 5-dose program

Inoculate 1 dose of Investigational vaccine each on 0, 3, 7, 14, 28 days, by intramuscular injection of deltoid muscle of upper arm

BIOLOGICAL

Freeze-dried human rabies vaccine (Vero cells) Zhifeilongkoma - 4-dose program

Inoculate 1 dose of Investigational vaccine each on both arms on day 0, and 1 dose each on day 7 and 21, by intramuscular injection of deltoid muscle of upper arm

BIOLOGICAL

Freeze-dried human rabies vaccine (Vero cells) Chengda - 5-dose program

Inoculate 1 dose of control vaccine each on 0, 3, 7, 14, 28 days, by intramuscular injection of deltoid muscle of upper arm

BIOLOGICAL

Freeze-dried human rabies vaccine (Vero cells) Chengda - 4-dose program

Inoculate 1 dose of control vaccine each on both arms on day 0, and 1 dose each on day 7 and 21, by intramuscular injection of deltoid muscle of upper arm

Trial Locations (1)

410005

Hunan Provincial Center for Disease Control and Prevention, Changsha

All Listed Sponsors
lead

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

INDUSTRY

NCT04852068 - A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells) | Biotech Hunter | Biotech Hunter